GBLX
Price:
$0.0002
Market Cap:
$81.41K
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.[Read more]
Industry
Biotechnology
IPO Date
2008-05-12
Stock Exchange
PNK
Ticker
GBLX
According to GB Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.83M. This represents a change of -62.12% compared to the average of 4.83M of the last 4 quarters.
The mean historical Enterprise Value of GB Sciences, Inc. over the last ten years is 22.03M. The current 1.83M Enterprise Value has changed 730.00% with respect to the historical average. Over the past ten years (40 quarters), GBLX's Enterprise Value was at its highest in in the December 2017 quarter at 114.17M. The Enterprise Value was at its lowest in in the June 2014 quarter at 1.66M.
Average
22.03M
Median
14.73M
Minimum
3.89M
Maximum
67.25M
Discovering the peaks and valleys of GB Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.73%
Maximum Annual Enterprise Value = 67.25M
Minimum Annual Increase = -59.97%
Minimum Annual Enterprise Value = 3.89M
Year | Enterprise Value | Change |
---|---|---|
2024 | 3.89M | -49.66% |
2023 | 7.73M | -23.33% |
2022 | 10.08M | -52.80% |
2021 | 21.35M | 19.27% |
2020 | 17.90M | -59.97% |
2019 | 44.71M | -33.52% |
2018 | 67.25M | 126.61% |
2017 | 29.68M | 156.73% |
2016 | 11.56M | 86.45% |
2015 | 6.20M | 42.14% |
The current Enterprise Value of GB Sciences, Inc. (GBLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.23M
5-year avg
12.19M
10-year avg
22.03M
GB Sciences, Inc.’s Enterprise Value is less than Biostage, Inc. (57.66M), less than Antibe Therapeutics Inc. (4.56M), less than Awakn Life Sciences Corp. (3.92M), less than Tryp Therapeutics Inc. (7.54M), less than America Great Health (12.38M), less than Theralink Technologies, Inc. (19.38M), less than Adhera Therapeutics, Inc. (0), less than SciSparc Ltd. (10.80M), greater than Cellectis S.A. (247.74K), less than Biotron Limited (144.28M), less than Regenicin, Inc. (19.39M), greater than AXIM Biotechnologies, Inc. (15.35K), less than Bioasis Technologies Inc. (7.85M), less than MultiCell Technologies, Inc. (39.49M), greater than Health Sciences Group, Inc. (50.10K), less than Wesana Health Holdings Inc. (0), greater than BetterLife Pharma Inc. (358.19K), less than Covalon Technologies Ltd. (0), less than null (16.00M), less than null (85.64M),
Company | Enterprise Value | Market cap |
---|---|---|
57.66M | $57.82M | |
4.56M | $11.45M | |
3.92M | $3.33M | |
7.54M | $5.42M | |
12.38M | $10.59M | |
19.38M | $615.15K | |
0 | $1.44K | |
10.80M | $2.31M | |
247.74K | $183.12M | |
144.28M | $13.08M | |
19.39M | $15.35K | |
15.35K | $1.45M | |
7.85M | $28.44M | |
39.49M | $50.01K | |
50.10K | $187.09K | |
0 | $171.26K | |
358.19K | $10.22M | |
0 | $67.67M | |
16.00M | $0 | |
85.64M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GB Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GB Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GB Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for GB Sciences, Inc. (GBLX)?
What is the 3-year average Enterprise Value for GB Sciences, Inc. (GBLX)?
What is the 5-year average Enterprise Value for GB Sciences, Inc. (GBLX)?
How does the current Enterprise Value for GB Sciences, Inc. (GBLX) compare to its historical average?